Page last updated: 2024-10-20

pyridine and Tuberculosis, Multidrug-Resistant

pyridine has been researched along with Tuberculosis, Multidrug-Resistant in 2 studies

azine : An organonitrogen compound of general structure RCH=N-N=CHR or RR'C=N-N=CRR'.

Tuberculosis, Multidrug-Resistant: Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Patel, H2
Chaudhari, K1
Jain, P1
Surana, S2
Jadhav, H1
Ansari, I1
Pawara, R1

Other Studies

2 other studies available for pyridine and Tuberculosis, Multidrug-Resistant

ArticleYear
Synthesis and in vitro antitubercular activity of pyridine analouges against the resistant Mycobacterium tuberculosis.
    Bioorganic chemistry, 2020, Volume: 102

    Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Stru

2020
Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors.
    European journal of medicinal chemistry, 2019, Apr-01, Volume: 167

    Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tub

2019